{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antiviral", "Gunnera perpensa", "Punicalagin", "Punicalin", "SARS-CoV-2", "UPLC-IMS-HRMS"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35419694", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "04"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1007/s00216-022-04041-3"], "Journal": {"ISSN": "1618-2650", "JournalIssue": {"Volume": "414", "Issue": "13", "PubDate": {"Year": "2022", "Month": "May"}}, "Title": "Analytical and bioanalytical chemistry", "ISOAbbreviation": "Anal Bioanal Chem"}, "ArticleTitle": "Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding.", "Pagination": {"StartPage": "3971", "EndPage": "3985", "MedlinePgn": "3971-3985"}, "Abstract": {"AbstractText": ["SARS-CoV-2, the causative agent of COVID-19, continues to cause global morbidity and mortality despite the increasing availability of vaccines. Alongside vaccines, antivirals are urgently needed to combat SARS-CoV-2 infection and spread, particularly in resource-limited regions which lack access to existing therapeutics. Small molecules isolated from medicinal plants may be able to block cellular entry by SARS-CoV-2 by antagonising the interaction of the viral spike glycoprotein receptor-binding domain (RBD) with the host angiotensin-converting enzyme II (ACE2) receptor. As the medicinal plant Gunnera perpensa L. is being used by some South African traditional healers for SARS-CoV-2/COVID-19 management, we hypothesised that it may contain chemical constituents that inhibit the RBD-ACE2 interaction. Using a previously described AlphaScreen-based protein interaction assay, we show here that the DCM:MeOH extract of G. perpensa readily disrupts RBD (USA-WA1/2020)-ACE2 interactions with a half-maximal inhibition concentration (IC<sub>50</sub>) of\u2009<\u20090.001\u00a0\u00b5g/mL, compared to an IC<sub>50</sub> of 0.025\u00a0\u00b5g/mL for the control neutralising antibody REGN10987. Employing hyphenated analytical techniques like UPLC-IMS-HRMS (method developed and validated as per the International Conference on Harmonization guidelines), we identified two ellagitannins, punicalin (2.12% w/w) and punicalagin (1.51% w/w), as plant constituents in the DCM:MeOH extract of G. perpensa which antagonised RBD-ACE2 binding with respective IC<sub>50</sub>s of 9 and 29\u00a0nM. This good potency makes both compounds promising leads for development of future entry-based SARS-CoV-2 antivirals. The results also highlight the advantages of combining reverse pharmacology (based on medicinal plant use) with hyphenated analytical techniques to expedite identification of urgently needed antivirals."], "CopyrightInformation": "\u00a9 2022. Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": ["0000-0003-1095-365X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria, South Africa."}], "LastName": "Invernizzi", "ForeName": "Luke", "Initials": "L"}, {"Identifier": ["0000-0001-7692-3256"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria, South Africa."}], "LastName": "Moyo", "ForeName": "Phanankosi", "Initials": "P"}, {"Identifier": ["0000-0001-8465-8739"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA, USA."}], "LastName": "Cassel", "ForeName": "Joel", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pure Herbal Medicine, Uitenhage, South Africa."}], "LastName": "Isaacs", "ForeName": "Freddie J", "Initials": "FJ"}, {"Identifier": ["0000-0002-2184-5980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA, USA."}], "LastName": "Salvino", "ForeName": "Joseph M", "Initials": "JM"}, {"Identifier": ["0000-0001-5799-6759"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA, USA."}], "LastName": "Montaner", "ForeName": "Luis J", "Initials": "LJ"}, {"Identifier": ["0000-0002-8991-6490"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Wistar Institute, Philadelphia, PA, USA."}], "LastName": "Tietjen", "ForeName": "Ian", "Initials": "I"}, {"Identifier": ["0000-0002-6512-304X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, University of Pretoria, Pretoria, South Africa. vinesh.maharaj@up.ac.za."}], "LastName": "Maharaj", "ForeName": "Vinesh", "Initials": "V"}], "GrantList": [{"GrantID": "L.J.M.", "Agency": "Wistar Discovery Fund", "Country": ""}, {"GrantID": "J.M.S.", "Agency": "Wistar Discovery Fund", "Country": ""}, {"GrantID": "CIHR PJT-153057", "Agency": "Canadian Institutes for Health Research", "Country": ""}, {"GrantID": "DST/CON 0031/2019", "Agency": "Department of Science and Innovation, South Africa", "Country": ""}, {"GrantID": "I.T.", "Agency": "Commonwealth of Pennsylvania", "Country": ""}, {"GrantID": "L.J.M.", "Agency": "Commonwealth of Pennsylvania", "Country": ""}, {"GrantID": "J.M.S.", "Agency": "Commonwealth of Pennsylvania", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Anal Bioanal Chem", "NlmUniqueID": "101134327", "ISSNLinking": "1618-2642"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "South Africa"}, {"QualifierName": ["chemistry"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Ibn-Mohammed T, Mustapha KB, Godsell J, Adamu Z, Babatunde KA, Akintade DD, Acquaye A, Fujii H, Ndiaye MM, Yamoah FA, Koh SCL. A critical review of the impacts of COVID-19 on the global economy and ecosystems and opportunities for circular economy strategies. Resour Conserv Recycl. 2021;164. 10.1016/j.resconrec.2020.105169.", "ArticleIdList": ["PMC7505605", "32982059"]}, {"Citation": "Saladino V, Algeri D, Auriemma V. The psychological and social impact of Covid-19: new perspectives of well-being. Front Psychol. 2020;11. 10.3389/fpsyg.2020.577684.", "ArticleIdList": ["PMC7561673", "33132986"]}, {"Citation": "Caniels TG, Bontjer I, van der Straten K, Poniman M, Burger JA, Appelman B, Lavell HAA, Oomen M, Godeke GJ, Valle C, M\u00f6gling R, van Willigen HDG, Wynberg E, Schinkel M, van Vught LA, Guerra D, Snitselaar JL, Chaturbhuj DN, Martin IC, Moore JP, de Jong MD, Reusken C, Sikkens JJ, Bomers MK, de Bree GJ, van Gils MJ, Eggink D, Sanders RW. Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination. Sci Adv. 2021;7. 10.1126/sciadv.abj5365.", "ArticleIdList": ["PMC8442901", "34516917"]}, {"Citation": "Kumar S, Maurya VK, Prasad AK, Bhatt MLB, Saxena SK. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV) Virus Dis. 2020;31:13\u201321. doi: 10.1007/s13337-020-00571-5.", "ArticleIdList": ["10.1007/s13337-020-00571-5", "PMC7085496", "32206694"]}, {"Citation": "Elsawah HK, Elsokary MA, Abdallah MS, ElShafie AH. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: systematic review and meta-analysis including network meta-analysis. Rev Med Virol. 2021;31. 10.1002/rmv.2187.", "ArticleIdList": ["33128490"]}, {"Citation": "Kabinger F, Stiller C, Schmitzov\u00e1 J, Dienemann C, Kokic G, Hillen HS, H\u00f6bartner C, Cramer P. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28:740\u2013746. doi: 10.1038/s41594-021-00651-0.", "ArticleIdList": ["10.1038/s41594-021-00651-0", "PMC8437801", "34381216"]}, {"Citation": "Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre R, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;4784:4.", "ArticleIdList": ["34726479"]}, {"Citation": "Xiu S, Dick A, Ju H, Mirzaie S, Abdi F, Cocklin S, Zhan P, Liu X. Inhibitors of SARS-CoV-2 entry: current and future opportunities. J Med Chem. 2020;63:12256\u201312274. doi: 10.1021/acs.jmedchem.0c00502.", "ArticleIdList": ["10.1021/acs.jmedchem.0c00502", "PMC7315836", "32539378"]}, {"Citation": "Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260\u20131263. doi: 10.1126/science.abb2507.", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Mm C. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564\u2013582. doi: 10.1128/CMR.12.4.564.", "ArticleIdList": ["10.1128/CMR.12.4.564", "PMC88925", "10515903"]}, {"Citation": "Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, Barreca D, Weckwerth W, Supuran CT, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200\u2013216. doi: 10.1038/s41573-020-00114-z.", "ArticleIdList": ["10.1038/s41573-020-00114-z", "PMC7841765", "33510482"]}, {"Citation": "Du R, Cooper L, Chen Z, Lee H, Rong L, Cui Q. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Res. 2021;190:105075. doi: 10.1016/j.antiviral.2021.105075.", "ArticleIdList": ["10.1016/j.antiviral.2021.105075", "PMC8052511", "33872675"]}, {"Citation": "Li H, Xu F, Liu C, Cai A, Dain JA, Li D, Seeram NP, Cho BP, Ma H. Inhibitory effects and surface plasmon resonance-based binding affinities of dietary hydrolyzable tannins and their gut microbial metabolites on SARS-CoV-2 main protease. J Agric Food Chem. 2021;69:12197\u201312208. doi: 10.1021/acs.jafc.1c03521.", "ArticleIdList": ["10.1021/acs.jafc.1c03521", "PMC8491554", "34586788"]}, {"Citation": "Nair MS, Huang Y, Fidock DA, Towler MJ, Weathers PJ. Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta. J Ethnopharmacol. 2021;284:114797. 10.1016/j.jep.2021.114797.", "ArticleIdList": ["PMC8559441", "34737005"]}, {"Citation": "Tietjen I, Cassel J, Register ET, Zhou XY, Messick TE, Keeney F, Lu LD, Beattie KD, Rali T, Tebas P, Ertl HCJ, Salvino JM, Davis RA, Montaner LJ. The natural stilbenoid (\u2013)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants. Antimicrob Agents Chemother. 2021;65. 10.1128/aac.00772-21.", "ArticleIdList": ["PMC8597786", "34543092"]}, {"Citation": "Mammo FK, Mohanlall V, Shode FO. Gunnera perpensa L a multi-use ethnomedicinal plant species in South Africa. Afr J Sci Technol Innov Dev. 2017;9:77\u201383. doi: 10.1080/20421338.2016.1269458.", "ArticleIdList": ["10.1080/20421338.2016.1269458"]}, {"Citation": "Hutchings A, Scott AH, Lewis G, Bunningham AB. Zulu medicinal plants: an inventory. Pietenmaritzburg: University of Natal Press; 1996."}, {"Citation": "Thornburg CC, Britt JR, Evans JR, Akee RK, Whitt JA, Trinh SK, Harris MJ, Thompson JR, Ewing TL, Shipley SM, Grothaus PG, Newman DJ, Schneider JP, Grkovic T, O\u2019Keefe BR. NCI program for natural product discovery: a publicly-accessible library of natural product fractions for high-throughput screening. ACS Chem Biol. 2018;13:2484\u20132497. doi: 10.1021/acschembio.8b00389.", "ArticleIdList": ["10.1021/acschembio.8b00389", "PMC8130845", "29812901"]}, {"Citation": "Fischer UA, Carle R, Kammerer DR. Identification and quantification of phenolic compounds from pomegranate (Punica granatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn. Food Chem. 2011;127:807\u2013821. doi: 10.1016/j.foodchem.2010.12.156.", "ArticleIdList": ["10.1016/j.foodchem.2010.12.156", "23140740"]}, {"Citation": "Puljula E, Walton G, Woodward MJ, Karonen M. Antimicrobial activities of ellagitannins against Clostridiales perfringens, Escherichia coli, Lactobacillus plantarum and Staphylococcus aureus. Molecules. 2020;25. 10.3390/molecules25163714.", "ArticleIdList": ["PMC7465317", "32824081"]}, {"Citation": "ICH Validation of analytical procedures text and methodology Q2 (R1) International Conference on Harmonization 2005, Geneva Switzerland. 10.1002/9781118532331.ch23."}, {"Citation": "Starr TN, Greaney AJ, Addetia A, Hannon WW, Choudhary MC, Dingens AS, Li JZ, Bloom JD. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. 2021;371:850\u2013854. doi: 10.1126/science.abf9302.", "ArticleIdList": ["10.1126/science.abf9302", "PMC7963219", "33495308"]}, {"Citation": "Teixeira N, Nabais P, de Freitas V, Lopes JA, Melo MJ. In-depth phenolic characterization of iron gall inks by deconstructing representative Iberian recipes. Sci Rep. 2021;11:1\u201311. doi: 10.1038/s41598-021-87969-3.", "ArticleIdList": ["10.1038/s41598-021-87969-3", "PMC8065154", "33893347"]}, {"Citation": "Lu J, Ding K, Yuan Q. Determination of punicalagin isomers in pomegranate husk. Chromatographia. 2008;68:303\u2013306. doi: 10.1365/s10337-008-0699-y.", "ArticleIdList": ["10.1365/s10337-008-0699-y"]}, {"Citation": "Raut AA, Chorghade MS, Vaidya ADB. Reverse pharmacology. Elsevier Inc.; 2017. 10.1016/B978-0-12-801814-9.00004-0."}, {"Citation": "Lanucara F, Holman SW, Gray CJ, Eyers CE. The power of ion mobility-mass spectrometry for structural characterization and the study of conformational dynamics. Nat Chem. 2014;6:281\u2013294. doi: 10.1038/nchem.1889.", "ArticleIdList": ["10.1038/nchem.1889", "24651194"]}, {"Citation": "Zhou Z, Luo M, Chen X, Yin Y, Xiong X, Wang R, Zhu ZJ. Ion mobility collision cross-section atlas for known and unknown metabolite annotation in untargeted metabolomics. Nat Commun. 2020;11:1\u201313. doi: 10.1038/s41467-020-18171-8.", "ArticleIdList": ["10.1038/s41467-020-18171-8", "PMC7455731", "32859911"]}, {"Citation": "Goshawk J, Barknowitz G, Mccullagh M. The development of a natural products library using ion - mobility enabled mass spectrometry 2019:2019. 10.13140/RG.2.2.16592.25600."}, {"Citation": "Giles K, Ujma J, Wildgoose J, Pringle S, Richardson K, Langridge D, Green M. A cyclic ion mobility-mass spectrometry system. Anal Chem. 2019;91:8564\u20138573. doi: 10.1021/acs.analchem.9b01838.", "ArticleIdList": ["10.1021/acs.analchem.9b01838", "31141659"]}, {"Citation": "Ujma J, Ropartz D, Giles K, Richardson K, Langridge D, Wildgoose J, Green M, Pringle S. Cyclic ion mobility mass spectrometry distinguishes anomers and open-ring forms of pentasaccharides. J Am Soc Mass Spectrom. 2019;30:1028\u20131037. doi: 10.1007/s13361-019-02168-9.", "ArticleIdList": ["10.1007/s13361-019-02168-9", "PMC6517361", "30977045"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "21"}, {"Year": "2022", "Month": "3", "Day": "23"}, {"Year": "2022", "Month": "2", "Day": "21"}, {"Year": "2022", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "14", "Hour": "5", "Minute": "23"}, {"Year": "2022", "Month": "4", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35419694", "PMC9007697", "10.1007/s00216-022-04041-3", "10.1007/s00216-022-04041-3"]}}], "PubmedBookArticle": []}